BC Week In Review | Sep 1, 2014
Financial News

Med BioGene proposes private placement of units

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date announced: 2014-08-15   Type: Private placement of units   To be raised: C$200,000 ($183,740)   Units: 4 million   Price: C$0.05 (unit)  ...
BC Week In Review | Mar 31, 2014
Clinical News

GeneFx Lung diagnostic data

A validation study analyzing 181 frozen, resected stage I/II NSCLC tumor specimens showed that Med BioGene's GeneFx Lung classified the samples into high- and low-risk prognostic groups with significantly different OS (p=0.012). In a subgroup...
BC Week In Review | Mar 31, 2014
Clinical News

GeneFx Lung regulatory update

Med BioGene said Precision Therapeutics received U.S. approval to perform GeneFx Lung testing in its CLIA-certified laboratory. The 15-gene expression-based assay identifies patients with early stage non-small cell lung cancer (NSCLC) who are at higher...
BC Week In Review | Sep 9, 2013
Company News

Med BioGene diagnostic news

Diagnostic company Med BioGene said four shareholders discontinued a petition against the company that was filed in June in the British Columbia Supreme Court. The petition made claims against the company relating to the adoption...
BC Week In Review | Sep 2, 2013
Company News

Med BioGene, Precision Therapeutics, Signal Genetics LLC diagnostic news

Med BioGene said it and commercialization partner Precision settled all remaining claims under a breach of contract suit filed by Signal Genetics in the Supreme Court for the County of New York. Under the terms...
BC Week In Review | Jun 17, 2013
Company News

Med BioGene diagnostic news

Diagnostic company Med BioGene said that four shareholders filed a petition in the British Columbia Supreme Court. The petition makes claims against the company relating to the adoption of the Advance Notice Policy by the...
BC Week In Review | Jun 3, 2013
Financial News

Med BioGene completes warrant exercise

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date completed: 5/24/13   Type: Warrant exercise   Raised: C$231,798 (US$224,612)   Shares: 2.3 million   Price: C$0.10   Shares after offering: 79.9 million...
BC Week In Review | Mar 4, 2013
Company News

Med BioGene, Precision Therapeutics, Signal Genetics LLC diagnostic news

Med BioGene said the Supreme Court for the County of New York granted the company's motion for partial summary judgment to dismiss several claims under a breach of contract suit filed by Signal Genetics. The...
BC Week In Review | Feb 6, 2012
Financial News

Med BioGene withdraws follow-on

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date announced: 2/2/12   Type: Follow-on   Underwriter: Rodman   Note: Med BioGene said it will not proceed with plans to list its shares...
BC Week In Review | May 23, 2011
Financial News

Med BioGene completes private placement of units

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date completed: 5/19/11   Type: Private placement of units   Raised: C$210,000 (US$216,489)   Units: 4.2 million   Price: C$0.05 (unit)   Shares after...
Items per page:
1 - 10 of 27
BC Week In Review | Sep 1, 2014
Financial News

Med BioGene proposes private placement of units

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date announced: 2014-08-15   Type: Private placement of units   To be raised: C$200,000 ($183,740)   Units: 4 million   Price: C$0.05 (unit)  ...
BC Week In Review | Mar 31, 2014
Clinical News

GeneFx Lung diagnostic data

A validation study analyzing 181 frozen, resected stage I/II NSCLC tumor specimens showed that Med BioGene's GeneFx Lung classified the samples into high- and low-risk prognostic groups with significantly different OS (p=0.012). In a subgroup...
BC Week In Review | Mar 31, 2014
Clinical News

GeneFx Lung regulatory update

Med BioGene said Precision Therapeutics received U.S. approval to perform GeneFx Lung testing in its CLIA-certified laboratory. The 15-gene expression-based assay identifies patients with early stage non-small cell lung cancer (NSCLC) who are at higher...
BC Week In Review | Sep 9, 2013
Company News

Med BioGene diagnostic news

Diagnostic company Med BioGene said four shareholders discontinued a petition against the company that was filed in June in the British Columbia Supreme Court. The petition made claims against the company relating to the adoption...
BC Week In Review | Sep 2, 2013
Company News

Med BioGene, Precision Therapeutics, Signal Genetics LLC diagnostic news

Med BioGene said it and commercialization partner Precision settled all remaining claims under a breach of contract suit filed by Signal Genetics in the Supreme Court for the County of New York. Under the terms...
BC Week In Review | Jun 17, 2013
Company News

Med BioGene diagnostic news

Diagnostic company Med BioGene said that four shareholders filed a petition in the British Columbia Supreme Court. The petition makes claims against the company relating to the adoption of the Advance Notice Policy by the...
BC Week In Review | Jun 3, 2013
Financial News

Med BioGene completes warrant exercise

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date completed: 5/24/13   Type: Warrant exercise   Raised: C$231,798 (US$224,612)   Shares: 2.3 million   Price: C$0.10   Shares after offering: 79.9 million...
BC Week In Review | Mar 4, 2013
Company News

Med BioGene, Precision Therapeutics, Signal Genetics LLC diagnostic news

Med BioGene said the Supreme Court for the County of New York granted the company's motion for partial summary judgment to dismiss several claims under a breach of contract suit filed by Signal Genetics. The...
BC Week In Review | Feb 6, 2012
Financial News

Med BioGene withdraws follow-on

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date announced: 2/2/12   Type: Follow-on   Underwriter: Rodman   Note: Med BioGene said it will not proceed with plans to list its shares...
BC Week In Review | May 23, 2011
Financial News

Med BioGene completes private placement of units

Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C.   Business: Diagnostic, Pharmacogenetics   Date completed: 5/19/11   Type: Private placement of units   Raised: C$210,000 (US$216,489)   Units: 4.2 million   Price: C$0.05 (unit)   Shares after...
Items per page:
1 - 10 of 27